Category

Clinical Studies

Childhood Diseases

By | Clinical Studies

Project Description

Dr Isaac Golden of Australia conducted a 15 year clinical study and ongoing trials. The results of this study, including the safety and efficacy of HP, are published in Dr. Golden’s recent publication Homeoprophylaxis – A Fifteen Year Clinical Study. His findings included a 90% effectiveness rate for preventing pertussis in those children exposed. Additionally, he found that long term health outcomes were improved for those participating in the HP program. They had fewer ear infections, colds, sore throats and asthma.

Case Study: Meningitis

By | Clinical Studies

Project Description

In 1974 there was an epidemic of meningitis in Brazil.  Dr. Francisco Eizayaga gave 18,640 children the Brazil Meningitis Case Study meningitis Case Study: Meningitis Brazil Meningitis Studyhomeoprophylactic remedy called meningococcinum. Only four cases of the illness were found. In the untreated group of 6,340 children, there were thirty-two cases found.

The study was repeated in 1988 with individuals between the ages of 0-20 years old. In the group of 65,826 treated with homeoprophylaxis, only one case of meningitis was reported in the six months following the study. Of the 25,532 untreated individuals, seven cases were reported during the same time. Twelve months later, the follow-up reported three cases in the protected group and thirteen cases in the unprotected group. This reflects eighteen times the disease attack rate in the untreated group.

Statistical analysis demonstrated homeoprophylaxis displayed 95% protection from contracting meningitis in children under six months old and 91% protection in children over 12 months old. There were no deaths, no adverse effects, and no side effects from the use of homeoprophylaxis.

Leptospirosis

By | Clinical Studies

Project Description

Dr Gustavo Bracho, an immunologist with the Carlos J. Finlay Institute, a world renowned center for vaccine research and production in Havana, Cuba used HP for 2.3 million people in 2007 and 2008. Dr. Bracho is Advisor to the President and General Director of Finlay Institute, and head of the Homeopathy and Biotherapic Projects at the Institute. He is an experienced researcher in molecular and cellular biology, and has headed the Adjuvant Group within the Immunology Department of Finlay.  

The PubMed study states:

CONCLUSIONS: The homeoprophylactic approach was associated with a large reduction of disease incidence and control of the epidemic. The results suggest the use of HP as a feasible tool for epidemic control, further research is warranted.[i]
 [i] PubMed 2014. Retrieved from: http://www.ncbi.nlm.nih.gov/pubmed/20674839 Bracho G1, Varela E, Fernández R, Ordaz B, Marzoa N, Menéndez J, García L, Gilling E, Leyva R, Rufín R, de la Torre R, Solis RL, Batista N, Borrero R, Campa C. Large-scale application of highly-diluted bacteria for Leptospirosis epidemic control. Homeopathy. 2010 Jul;99(3):156-66. doi: 10.1016/j.homp.2010.05.009.